Carregant...

Strong, but Age-Dependent, Protection Elicited by a Deoxyribonucleic Acid/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine

Background. In this study, we analyzed the protective efficacy of a simian immunodeficiency virus (SIV) macaque 239 (SIVmac239) analogue of the clinically tested GOVX-B11 deoxyribonucleic acid (DNA)/modified vaccinia Ankara (MVA) human immunodeficiency virus vaccine. Methods. The tested vaccine used...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Open Forum Infect Dis
Autors principals: Chamcha, Venkateswarlu, Kannanganat, Sunil, Gangadhara, Sailaja, Nabi, Rafiq, Kozlowski, Pamela A., Montefiori, David C., LaBranche, Celia C., Wrammert, Jens, Keele, Brandon F., Balachandran, Harikrishnan, Sahu, Sujata, Lifton, Michelle, Santra, Sampa, Basu, Rahul, Moss, Bernard, Robinson, Harriet L., Amara, Rama Rao
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2016
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4800464/
https://ncbi.nlm.nih.gov/pubmed/27006959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofw034
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!